Page 1,602«..1020..1,6011,6021,6031,604..1,6101,620..»

Diabetes is on the rise in America’s kids and experts don’t know why – USA TODAY

Posted: April 14, 2017 at 10:40 pm

A new study is the first to look at diabetes diagnosis trends in America's youth. Video provided by Newsy Newslook

The rate at which America's kids are diagnosed with diabetes is climbing and researchers don't know why.(Photo: AndreyPopov, Getty Images/iStockphoto)

The rate at which America's kids are diagnosed with diabetes is climbing and researchers don't know why.

A first-ever study of new diabetes diagnoses of U.S. youth under age 20 found both Types 1 and 2 diabetes surged from 2002-2012.

The diagnosis of new cases of Type 2 diabetes, associated with obesity, increased about 5% each year from 2002 to 2012, the study said, while new cases of Type 1, the most common form for young people, went up about 2% every year.

The National Institutes of Health, which funded the study along with the Centers for Disease Control and Prevention, said the cause of the rise is "unclear."

"These findings lead to many more questions," explained Dr. Barbara Linder, senior advisor for childhood diabetes research at NIH's National Institute of Diabetes and Digestive and Kidney Diseases. "The differences among racial and ethnic groups and between genders raise many questions. We need to understand why the increase in rates of diabetes development varies so greatly and is so concentrated in specific racial and ethnic groups."

Here's what happens to your body when you walk those recommended 10,000 steps

Sizing up summer footwear: Be wary of flip flops

The study, published Friday in theNew England Journal of Medicine,showed higher rates of diabetes diagnoses among minorities. Type 2 diabetes, which the CDC stated makes up about 90% to 95% of diagnosed diabetes cases, rose by 8.5% in Asian Americans ages 10-19. Blacks in the same age group saw a 6.3% increase, followed by a 3.1% bump in Hispanicsand whites at fewer than a 1%increase.

Hispanics saw the biggest rate increase of Type 1 diabetes with a 4.2% increase, followed by blacks at 2.2% and whites at 1.2%

In terms of gender, girls and women 10-19 saw a 6.2% increase in Type 2 diabetes, while men and boys of the same age experienced a 3.7% increase. Across all age groups, Type 1 diabetes increased 2.2% in males and 1.4% in females.

CDC epidemiologistDr. Giuseppina Imperatore said those who developdiabetes at a young age are at risk ofdeveloping complications from the disease earlier, loweringtheir quality of life, shorteninglife expectancy and increasing health care costs.

Follow Sean Rossman on Twitter: @SeanRossman

Read or Share this story: http://usat.ly/2pg0GpQ

See the original post:
Diabetes is on the rise in America's kids and experts don't know why - USA TODAY

Posted in Diabetes | Comments Off on Diabetes is on the rise in America’s kids and experts don’t know why – USA TODAY

Dining with Diabetes program offered | Community … – Washington Times Herald

Posted: April 14, 2017 at 10:40 pm

Do you have Type 2 diabetes? Would you like to learn more about your disease and how to live well reducing your health risks? If so, Purdue Extension has a great program for you.

The Purdue ExtensionKnox County office in partnership with the Daviess Co. Purdue Extension Service consists of four two-hour sessions that will be held from 5 p.m. to 7 p.m. on each Thursday during May with the first session scheduled on May 4 and the fourth session on May 25. Participants may also elect to have a follow-up session in June. The Dining with Diabetes program is open to those with diabetes, their family members and caretakers. The series of four sessions is $25/person or $35/couple. Pre-registration and payment is required no later than April 28. Participants are encouraged to attend all class sessions which will be held at the Knox County Extension Office, 4259 N. Purdue Road in Vincennes.

The educational programs and cooking school will help adults with type 2 diabetes control their blood sugar, to feel better, and reduce their risk of health complications. Those enrolling will learn how to prepare meals that are healthy, easy to prepare and taste good. Recipes will be demonstrated, and participants will have the opportunity to taste each one. Participants will also learn up-to-date information on nutrition, meal planning, exercise and how to understand common diabetes-related medical tests. Recipe and handouts will be given to each participant.

Diabetes is a very serious and costly disease, but research has shown that those who learn to manage their blood glucose (sugar) levels eat a healthy diet and exercise regularly can lower their risks of complications and lead a healthier and more productive life.

Purdue Extension Knox County and Daviess County are currently recruiting participants for this program. If you have been diagnosed with type 2 diabetes, or know someone and are part of the support system for an individual and are interested in being a part of this program, please call Purdue Extension office at 812-882-3509. Registration and program fee may be sent to: 4259 N. Purdue Road by April 28. The $25/$35 program fee includes educational classes, program materials and food sampling. Dining with Diabetes is offered statewide and is sponsored by Purdue Extension.

See more here:
Dining with Diabetes program offered | Community ... - Washington Times Herald

Posted in Diabetes | Comments Off on Dining with Diabetes program offered | Community … – Washington Times Herald

On the outside, you wouldn’t know what this crowd has in common. – Tristatehomepage.com

Posted: April 14, 2017 at 10:40 pm

On the outside, you wouldn't know what this crowd has in common.

"I thought everybody had diabetes when I was a kid because I had it when I was a year and a half old," Tim Alcorn says. Tim has been managing his type 1 diabetes for 61 years.

Looking in, the group is just a small number of the millions of people affected by type 1 diabetes.

Tim's wifeBecki Alcornsays,"It's nice to know there are that many people out there that can manage and manage well and to know there's that much life left for everybody."

For 10, 25, 50 and even 75 years...and multiple insulin shots a day, patients with type 1 diabetes were recognized with a Lilly Diabetes Journey Award.

Sean Kinslerhas been managing his diabetes for 35 years. He says, "It's kind of nice to be able to say I made it this long and I'm going to continue to make it as long as I can make it."

"I'm happy to be here and I'm very proud actually to make it 61 years," Tim says.

Local award recipients join the thousands of individuals who have received the honor since the award was first established in 1975.

"It's wonderful because anybody who doesn't have diabetes doesn't realize what he or anyone with diabetes has to do just to be able to live," Becki says.

"The doctors used to joke and say 'Oh yeah you'll be in a wheel chair you'll lose a leg your eyesight and all this stuff you have to be worried about," Kinsler says. "I said 'Doctor...not me bud, just wait I'm going to prove you wrong.'"

Some say seeing others functioning so well with the same disease gives them a personal goal. Others, thankful for the insulin pumps that have helped them live so long. Most patients, lifting their hats, or insulin pumps to a virtual toast.

"I appreciate the day and I appreciate being able to be one that gets an award," Kinsler says.

This is the first time Deaconess held the celebration and staff says they plan to continue doing these awards annually.

The rest is here:
On the outside, you wouldn't know what this crowd has in common. - Tristatehomepage.com

Posted in Diabetes | Comments Off on On the outside, you wouldn’t know what this crowd has in common. – Tristatehomepage.com

Governor Signs "Emerging Therapies Act of 2017" With Strongside … – Yahoo Finance

Posted: April 13, 2017 at 7:43 pm

LITTLE ROCK, Ark., April 12, 2017 /PRNewswire/ -- The Emerging Therapies Act of 2017 was signed into law by Governor Asa Hutchinson today, granting pilot access to State Employees and Teachers to Regenerative Injection Therapies as a treatment of orthopedic conditions on their health care plans. Arkansas now leads the country as the first state to adopt a policy to include these emerging therapies in state employee health insurance.

"This could potentially save the state $100 Million using regenerative medicine as an alternative to surgery or pharmaceuticals for orthopedic conditions," states Morgan Pile, Executive Vice President of Strongside Solutions, who worked with HB2014 sponsors Senator David Sanders, Rep Joe Farrer and Rep Scott Baltz to bring the opportunity to the state. "Regenerative Injection Therapies like Platelet Rich Plasma (PRP), Bone Marrow Aspirate Concentrate (BMAC) and Amniotic tissue have been shown to be effective treatments with up to an 80% savings of surgical costs while virtually absent of complications," Wendell Strickland, founder and managing partner of Strongside Solutions is pleased to be a part of developing programs that prevent fraud, waste and abuse in medical and prescription drug plans for many years. "We have worked with state, county and city governments as well as private employers' self-funded medical plans to reduce cost and maintain viable healthcare programs. Regenerative Medicine in another program we use to help our clients reduce healthcare costs and reach their goals. Employers with self-funded medical and prescription programs turn to Strongside Solutions to deliver these and other programs across the United States," Strickland said.

Representative Scott Baltz has personal experience with these therapies, as his wife was advised that a surgical intervention might not provide more than 2 years' relief of her symptoms, and could ultimately leave her with worse symptoms than she was experiencing. They elected to use Regenerative Injection Therapy (RIT) instead of a surgical procedure, and 4 years later she is still experiencing relief that allows her to raise her grandchildren and live a normal life. Representative Baltz realized that RIT was "something that could help other Arkansans if insurance would cover it." His wife testified to the Employee Benefits Division (EBD) about the merits of this emerging therapy in 2014. In the amended bill, the Employee Benefits Division will conduct a pilot study for state employees and teachers' health plans. The EBD will set up the parameters of the study including assuring that only certified providers, settings and applications will be available for reimbursement under the health plan. At the end of 2018, the full study results will be reviewed with a goal of providing all insured Arkansans access to these therapies.

"Arkansas has always been a leader in medical innovation. This is a major step forward for healthcare in our state," Dr. Christopher Dougherty, orthopedic surgeon at Agility Center Orthopedics in Bentonville said. "The opportunity to offer a non-surgical solutions for an injury that formerly may have required surgery is both a time and money saver for the patient and society as a whole."

"The American Association of Orthopaedic Medicine (AAOM), the world's oldest educational organization dedicated to teaching Interventional Regenerative Orthopedic Medicine (IROM) was also a proponent of this bill passing. The 'Emerging Therapy Act of 2017' in Arkansas, is revolutionary in both vision and scope. Its implementation will forge a new path in healthcare delivery, and we are inspired by as well as committed to its success going forward," Dr. Thomas Bond, President-Elect of AAOM issued in a statement.

Dr. David L. Harshfield, Jr. is a pioneer in regenerative cellular therapy. "Regenerative Medicine moves away from the allopathic medicine (M.D.) model, where a physician matches a diagnosis to only a binary, pharmaceutical or surgical solution, and focuses instead on the "correction of medicine". The State of Arkansas will now give patients a choice beyond drugs or surgery. "We are not man-made, and no 'man' can heal us. Physicians must admit to patients that we only 'men' and as such, we can only help patients heal themselves. With Regenerative Medicine, physicians can help patients restore their health by utilizing the natural healing responses found within the body," said Harshfield. Dr. Harshfield, an Interventional Radiologist with specialization in musculoskeletal radiology and cellular medicine, has been exploring autologous (patient's own) adult stem cells since graduating from UAMS with Honors in 1981 and has become a leader in cellular restoration. Dr. Harshfield brings his expertise in cellular therapy to treat a variety of conditions without expensive, often dangerous surgery and pharmaceuticals to improve outcomes while reducing recovery and rehabilitation time. And unlike pharmaceutical and surgical options, there has never been a serious adverse event (SAE) associated with regenerative therapies when administered by credentialed physicians utilizing certified protocols.

Read More

See the original post here:
Governor Signs "Emerging Therapies Act of 2017" With Strongside ... - Yahoo Finance

Posted in Arkansas Stem Cells | Comments Off on Governor Signs "Emerging Therapies Act of 2017" With Strongside … – Yahoo Finance

Six U of A Students or Alumni Selected as NSF Graduate Research … – University of Arkansas Newswire

Posted: April 13, 2017 at 7:43 pm

Photo Submitted

Top, from left: Alex Khang, Larissa Markwardt, Kelly McKenzie; Bottom: Madeline Meier and Jordana Thibado

FAYETTEVILLE, Ark. Three University of Arkansas undergraduate students and three recent graduates have received National Science Foundation Graduate Research Fellowships for the upcoming academic year. The highly competitive awards are made to students in science, technology, engineering and mathematics and recognize academic excellence and the potential contribution that they will make to their field and to society at large.

The NSF Graduate Research Fellows are:

The sixth student, a recent graduate, has asked not to be named at this time.

Each fellowship is worth $34,000 per year and can be renewed for up to three years. Along with the renewable stipend, each students institution will receive $12,000 per year to offset tuition costs, bringing the total amount of funding awarded in these six fellowships to more than $800,000.

In addition to the Fellows, seven more U of A students received honorable mentions: undergraduates Christian Goodnow, David Jacobson and Christopher Matthews; current U of A graduate students Haley Brown, Hillary Fischer and Ashly Romero; and recent U of A graduate Michaela Mertz.

When our students receive highly competitive awards like the NSF Graduate Research Fellowships, I am reminded just how remarkable University of Arkansas students are. Not only are they intellectually curious and academically ambitious, but they also want to give back to their communities, said U of A Chancellor Joseph Steinmetz. The National Science Foundation recognizes outstanding students who are going to pursue research careers in a STEM field, but it also looks for those researchers who have an interest in the broader impacts of the work they do. These six University of Arkansas recipients are both stellar scientists and really great people, who are going to make differences in their fields and in our communities.

NSF FELLOWSHIP RECIPIENTS

Alex Khang graduated in 2016 with an honors degree in biomedical engineering from the College of Engineering. While an undergraduate, he researched Janus-type, polymer-protein nanofibers under the direction of Kartik Balachandran, assistant professor of biomedical engineering. Khang is currently pursuing a doctorate in biomedical engineering at the University of Texas at Austin.

Larissa Markwardt is a senior honors physics major in the J. William Fulbright College of Arts and Sciences. Her undergraduate research mentor is Bret Lehmer, assistant professor of physics. Markwardts undergraduate research focuses on X-ray binaries in nearby, face-on, spiral galaxies.

Kelly McKenzie is a senior honors electrical engineering and physics double major in the College of Engineering and Fulbright College. Her undergraduate research mentor is Morgan Ware, assistant professor of electrical engineering. In her research, she studies indium gallium nitride intermediate-band solar cells.

Madeline Meier is a senior honors chemistry major in Fulbright College. In her current research under David Paul, associate professor of chemistry, she studies biosensors. Their work resulted in a recent publication in the Journal of the Electrochemical Society, with Meier as a second author. She was also recently named a finalist for the National Institutes of Health Oxford-Cambridge Fellowship.

Jordana Thibado graduated in 2016 with an honors degree in chemistry from Fulbright College. Under the guidance of her mentor Roger Koeppe, distinguished professor of chemistry and biochemistry, she published a paper based on her undergraduate research in biochemistry as first author. She is currently pursuing a doctorate in physiology, biophysics, and systems biology at Weill Medical College of Cornell University in New York City.

The College of Engineering is extremely proud of Alex Khang and Kelly McKenzie, said John English, dean of the College of Engineering. The NSF Graduate Research Fellowships are highly sought after, very competitive awards. Both of these exceptional students have been very active in research, and talented faculty have supported their efforts every step of the way. Its a winning combination.

What is so striking about these amazing Fulbright College students who have been selected to receive these awards is the breadth of their studies, which range from biosensors to solar cells to neurodegenerative diseases to X-ray binaries in spiral galaxies, said Todd Shields, dean of Fulbright College. They are asking big questions in big fields, and the answers are already leading to publications in major journals. I am pleased and not surprised that these very capable students have been selected for this national recognition.

Since 1952, the National Science Foundation has awarded the highly competitive Graduate Research Fellowship to around 50,000 students in the STEM fields. The graduate fellowship program is one of the NSFs oldest and most highly competitive, with roots in the foundations original 1950 charter. Each year, approximately 2,000 applicants are selected through a rigorous NSF peer-review process. Each grant supports graduate study that leads to a research-based masters or doctoral degree. NSF Graduate Research Fellows are promising young mathematicians, scientists and engineers who are expected to pursue lifelong careers marked by significant contributions to research, teaching and industrial applications in science, mathematics and engineering. This group of fellowship recipients raises the total number of awardees from the U of A to 128.

U of A students and recent alumni interested in applying for scholarships and fellowships such as the NSF Graduate Research Fellowship should contact the Office of Nationally Competitive Awards at awards@uark.edu or 479-575-3771. More information is available at awards.uark.edu.

About the University of Arkansas: The U of A provides an internationally competitive education for undergraduate and graduate students in more than 200 academic programs. The university contributes new knowledge, economic development, basic and applied research, and creative activity while also providing service to academic and professional disciplines. The Carnegie Foundation classifies the U of A among only 2 percent of universities in America that have the highest level of research activity. U.S. News & World Report ranks the U of A among its top American public research universities. Founded in 1871, the U of A comprises 10 colleges and schools and maintains a low student-to-faculty ratio that promotes personal attention and close mentoring.

Editor-selected comments will be published below. No abusive material, personal attacks, profanity, spam or material of a similar nature will be considered for publication.

Read the original post:
Six U of A Students or Alumni Selected as NSF Graduate Research ... - University of Arkansas Newswire

Posted in Arkansas Stem Cells | Comments Off on Six U of A Students or Alumni Selected as NSF Graduate Research … – University of Arkansas Newswire

Biotechnology: navigating a minefield – Cordis News

Posted: April 13, 2017 at 7:42 pm

When it comes to getting biotechnology innovations to market, with commercial protection, it can be tough. Around three quarters of patent applications normally fail to cut it. Although biotechnology is recognised as being important for the economy and society, it can also be highly controversial attracting public protests

The European Patent Office (EPO) has faced opposition in the past, for instance, over patents relating to processes for re-engineering genes, for use in medical research into cancer treatment. These processes could apply to various animals, including great apes and that became a magnet for criticism from animal rights campaigners.

The number of patent filings for biotechnology increased by 0.3 percent in 2016, to 5,744 making it the tenth largest sector in its field.

Youris.com spoke to Benoit Battistelli, President of the EPO, about the role of patent protection and how it can aid biotechnology innovation and the wider bioeconomy despite the obstacles faced by some.

How much of a focus is the bioeconomy for patents and what are some of the key developments?

Biosciences play an important role in patent applications at the EPO, given the growing convergence of technologies, which is widely responsible for technical progress in a wide number of sectors. Such inventions are mainly found in industrial biotechnology, for instance, in the development of novel products such as new detergents, functional food or even new eco-friendly material in construction, such as pollution-eating concrete and self-healing concrete.

The area of clean energy production is also very important. For example, when it comes to using biomass as an energy source [editors note: In 2011, a Danish inventor won a European Inventor Award organised by the EPO for developing a system which increases the types of biomass fuels that can be used. Typically, biomass materials have to be dried before they can be used as fuel, but Jens Dall Bentzens furnace design can also burn materials with a moisture content of up to 60 percent. Hes since reported to have attracted interest from Europe and the US, selling the furnace to an American manufacturer, as well as building two others for use in Denmark].

Is the bioeconomy an increasing sector?

Biotech is among our top ten technical fields and it has increased. At the end of the patent granting process, its about 50 percent on average that become a patent. Its only 26 or 27 percent in the case of biotech. Why? Because it is a very sensitive issue and we are applying the patentability criteria very rigorously. There are huge European capacities in biotech and we have seen that we must find a good balance between the regulatory constraints and the economic capacities that this sector represents.

The position of the EPO is very clear and simple. There is an EU directive concerning biotech, which we respect and which we have integrated in our own legal framework, the European Patent Convention. Then you have the interpretations of the Directive by the European Court of Justice and we adapt our practice to these judgements.

Overall, how complicated is it to obtain a patent, and is it expensive?

I would not say that it is complicated, but it is a difficult process, because we always start from the basis that a patent is an exception to the principle of free trade, free industry, free competition. Globally, for around 20 to 25,000 euros, you can obtain a patent as the EPO. For this amount, 5,000 euros are the EPO fees and the rest is the fees of those who helped to draft a patent and then discuss it with the patent office.

So, with a patent, you are giving the holder the exclusive right of commercially exploiting his invention, for a certain period of time, a maximum 20 years.

By Damon Embling

Read this article:
Biotechnology: navigating a minefield - Cordis News

Posted in Biotechnology | Comments Off on Biotechnology: navigating a minefield – Cordis News

Biotechnology Education vs Industry Requirements: Where – BSI bureau (press release)

Posted: April 13, 2017 at 7:42 pm

Dr Vinay Rale shares his thoughts with BioSpectrum on current biotech education and the academia-industry gap

Dr Vinay Rale, Director, Symbiosis School of Biomedical Sciences (SSBS)

Brief recapitulation of genesis of Biotechnology in India A quick recapitulation of the genesis of Biotechnology in India will not be out of place to apprise the lay public. We essentially (and blindly) followed the USA in 1985 in initiating Biotechnology programs at Master's level at six select universities across India. In the 1970s, the ability to modify DNA molecules and the realization of the power of genetic engineering led prominent universities in the US to convince their Government to allocate huge funds to start

Biotechnology' - a term newly coined by them. The Indian model, first at Masters level, to cater to the need for trained manpower for the anticipated boom in the Biotechnology industry was supported by the Department of Biotechnology (DBT). Very soon a large number of institutions both in private and public sector followed suit to attract students. The wildfire spread to undergraduate programs equally rapidly. However, this led to two major disadvantages - the relegation of basic courses in Life Sciences such as Microbiology, Biochemistry, Zoology and Botany and severely inadequate infrastructure and untrained faculty. As a matter of fact, the first Masters programs supported by DBT at six prominent institutions in the country were turned to the advantage of the then faculty expertise, e.g., developmental biology turning a blind eye to the basic essentials that the students have to be proficient in.

A rough estimate of the students enrolled in Biotechnology at undergraduate and postgraduate levels suggests a number exceeding 100,000 at any given time. Also, some institutions offer a bouquet of 8 to 9 allied courses in Biotechnology. Naturally the demand-supply ratio is skewed. The curricula in Biotechnology tries to accommodate' as many subsets as possible with little attention to the fundamentals - especially at the undergraduate levels. Moreover, to overcome the infrastructure deficiency, a good number of students (especially at postgraduate level) are encouraged to bank upon either research institutes or industries to undertake dissertations.

Unfortunately, both categories of organizations take little interest in the welfare of such dissertation research; more so due to the unavailability of mentors from either side. Therefore-, little research done at such levels goes unnoticed. As a consequence-, it is estimated that well over 70 percent of Biotechnology students are considered as unemployable by industries. This is the net result of a large number of factors contributing to the creation of unfit student mass. Reliable sources indicate that industries now prefer to hire students trained in conventional Life Sciences like Microbiology and Biochemistry (also Chemistry) to meet their stringent requirements. The general complaint is that the Biotechnology students lack fundamentals. This is also the observation of this author over the decades.

Considering the seriousness of the Government to increase funding for the DBT and the intiative of the Biotechnology Industry Research Assistance Council (BIRAC) coupled with those of SIDBI and MSME to strengthen research in academia and foster strategic alliances between academia and industry, one can only expect better things to happen. However, like Biotechnology, Microbiology and Biochemistry programs too need nourishment.

Read more from the original source:
Biotechnology Education vs Industry Requirements: Where - BSI bureau (press release)

Posted in Biotechnology | Comments Off on Biotechnology Education vs Industry Requirements: Where – BSI bureau (press release)

Pennsylvania Biotechnology Center begins long-awaited expansion … – Bucks County Courier Times

Posted: April 13, 2017 at 7:42 pm

The Pennsylvania Biotechnology Center on Wednesday broke ground on a long-awaited expansion that will add laboratories, office space and at least 100 new jobs to its campus in Buckingham.

"This has become a real state resource," said biotechnology center President Timothy Block. "We can't exist in these two buildings anymore. We need to grow."

Because of the center's success, it's been a draw for scientists and entrepreneurs throughout the region. Lab space is at a premium, and there's a waiting list for tenants. The new wing is already 40 percent leased, Block said.

The first tenant, contract research organization FlowMetric Inc., credits the center with its growth. The company now has three dozen employees.

"I could have set up my company in New Jersey. But there was no place that was quite like this, and that has continued for us," said CEO Ren Capocasale.

"This center is why I do what I do."

While construction likely won't begin until the summer, biotech center officials chose Wednesday for the ceremonial groundbreaking in part because it also happened to be the 96th birthday of Joshua Feldstein, a longtime supporter for whom a wing of the center is named.

Feldstein was on hand for Wednesday's event, seated among a variety of state and local dignitaries that included state Rep. Marguerite Quinn, R-143, Doylestown, and state Sen. Chuck McIlhinney, R-10, Doylestown both longtime supporters of the center and Congressman Brian Fitzpatrick, R-8, Middletown.

"This is not a Republican or Democrat thing," said Quinn. "We've had support from both sides of the aisle, recognizing what you do here: jobs, cures and research. Well-paying jobs and phenomenal research."

First proposed in 2015, the expansion project stalled during a dispute between the Hepatitis B Foundation and Delaware Valley University. Unhappy with how the foundation was running the center's day-to-day operations, the university refused to sign off on the expansion plans.

The final project will cost between $12 million and $13 million, center officials said. That will be offset by a $4.6 million grant from the federal government and a $2 million state grant. The rest will be financed with a conventional loan awarded by Univest Bank.

Officials on Wednesday, however, weren't just celebrating the expansion. They were thinking about the future.

"We need to be thinking about what the next thing we're going to put the shovel in the ground (for) here with what's happening here," said Bucks County Commissioner Rob Loughery.

Block envisions a biotechnology hub within Bucks County one that equals the well-known Kendall Square area of Boston.

"There is a resource in Bucks County as vital and powerful, with as much potential, as the shale under the earth here," Block said. "That's what we're going to tap into."

View post:
Pennsylvania Biotechnology Center begins long-awaited expansion ... - Bucks County Courier Times

Posted in Biotechnology | Comments Off on Pennsylvania Biotechnology Center begins long-awaited expansion … – Bucks County Courier Times

Expert: Biotechnology will aid sustainable agricultural production – P.M. News

Posted: April 13, 2017 at 7:42 pm

Biotech

Prof. Benjamin Ubi, the President, (BSN), says the adoption of biotechnology will facilitate sustainable agricultural production in the country.

Ubi made the declaration in an interview with News Agency of Nigeria (NAN) in Abuja on Thursday

He said that the adoption of biotechnology applications was the panacea to the current food challenges facing the country.

Biotechnology, including genetic engineering and production of Genetically Modified Organisms (GMOs), provides powerful tools for the sustainable development of agriculture, fishery and forestry, as well as meeting the food needs of the population.

GMOs currently account for about 16 per cent of the worlds crops, particularly crops like soybean, maize, cotton and canola, and there are indications that the growing trend will continue.

So, we must eat what we grow and grow what we eat. This means we ought to produce more and agricultural biotechnology is a tool for achieving this, he said.

Ubi also pledged the support of the BSN for the efforts of National Biosafety Management Agency (NBMA) to harness the potential of modern biotechnology.

READ: Kwara International Vocational Centre gets equipment

BSN, as a stakeholder in biosafety, will continue to support NBMA; we should all be rest assured that no biotechnology product will be imposed on anyone.

Hunger and peace work hand-in-hand, so lack of hunger consequently promotes peace; therefore, biotechnology and its derivatives should be adopted for the benefit of Nigerians, while maintaining regulatory standards.

Biotechnology and biosafety stakeholders must, therefore, work in tandem with global bodies because Nigeria is not a pariah nation; we are a responsible and respected member of the global community, he said.

Ubi urged anti-GMO campaigners not to play politics with issues that could engender food security and alleviate poverty, saying that tangible efforts should be made to enhance the availability and affordability of high-quality foods via biotechnology applications.

I assure all that modern biotechnology had been found to be safe by global certification bodies.

All the same, informed criticism is good for checks and balances but it should not be allowed to be a clog the wheel of progress, he added.

Visit link:
Expert: Biotechnology will aid sustainable agricultural production - P.M. News

Posted in Biotechnology | Comments Off on Expert: Biotechnology will aid sustainable agricultural production – P.M. News

Nature Biotechnology Features ReadCoor as a 2016 Leading Spinout – PR Newswire (press release)

Posted: April 13, 2017 at 7:42 pm

CAMBRIDGE, Mass., April 12, 2017 /PRNewswire/ --ReadCoor, Inc. today announced that an article appearing in the April 2017 issue of Nature Biotechnology named the company among the 10 leading academic spinouts for 2016. Each year the journal identifies and features companies originating from academic institutions who have generated significant initial funding and who in the editors' assessment have demonstrated novel, potentially disruptive technology. In the words of the journal, "We believe these [ventures] represent some of the best science coming out of academia in 2016."

"It is a tremendous honor to be included in this group of amazing technologies and companies," said Shawn Marcell, ReadCoor co-founder and CEO. "The team at ReadCoor is excited to deliver on the promise this revolutionary platform holds."

The ReadCoor platform, called FISSEQ Fluorescent In-Situ Sequencing is the first application of in-situ spatial sequencing. ReadCoor was founded in 2014 by Richard Terry and George Church at the Harvard Wyss Institute, to bring Fluorescent In-Situ Sequencing into mainstream research use. Several key applications are being advanced including pathogen detection under a grant provided by the Bill & Melinda Gates Foundation, brain mapping or neural connectomics funded by IARPA, and drug development in areas such as central nervous system, neurodegenerative diseases, oncology, immunotherapy and gene therapy. Unlike traditional sequencing technologies, ReadCoor provides a method to pinpoint the precise locations of specific RNA molecules in intact tissue.

About ReadCoor

ReadCoor is leading the next generation of "omics" by delivering the first panomic spatial sequencing platform to researchers, clinicians, pharma and diagnostics companies, and ultimately patients. It is spearheading the charge with Fluorescent In-Situ Sequencing, a fundamental innovative technology that simultaneously integrates high throughput next generation sequencing, morphometric tissue analysis and three-dimensional spatial imaging. This uniquely powerful tool is the first and only implementation of "In-situ Sequencing" and will revolutionize the next phase in understanding the transcriptome, introducing vast new opportunities for important and meaningful clinical insights.

Contact Sam Inverso ReadCoor, Inc. Readcoor.com (617) 453-2660

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nature-biotechnology-features-readcoor-as-a-2016-leading-spinout-300438536.html

SOURCE ReadCoor, Inc.

http://www.readcoor.com

Read more:
Nature Biotechnology Features ReadCoor as a 2016 Leading Spinout - PR Newswire (press release)

Posted in Biotechnology | Comments Off on Nature Biotechnology Features ReadCoor as a 2016 Leading Spinout – PR Newswire (press release)

Page 1,602«..1020..1,6011,6021,6031,604..1,6101,620..»